Compare ABVC & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABVC | COSM |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 27.9M |
| IPO Year | 2009 | 2009 |
| Metric | ABVC | COSM |
|---|---|---|
| Price | $1.02 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 121.7K | ★ 3.4M |
| Earning Date | 11-02-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.14 | ★ 46.15 |
| EPS | ★ N/A | N/A |
| Revenue | $509,589.00 | ★ $65,271,815.00 |
| Revenue This Year | N/A | $23.79 |
| Revenue Next Year | $171.50 | $37.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $0.71 | $0.16 |
| 52 Week High | $3.39 | $1.32 |
| Indicator | ABVC | COSM |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 68.08 |
| Support Level | N/A | $0.27 |
| Resistance Level | N/A | $0.48 |
| Average True Range (ATR) | 0.00 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 72.90 |
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.